Avinger Shares Rise 40% on Launch of Image-Guided Device to Diagnose and Treat PAD

  ()
Shares of Avinger Inc. reached a new 52-week high after the company reported it initiated a full commercial launch of its Tigereye™ Image-Guided CTO Crossing Catheter system for diagnosing and treating peripheral artery disease. read more >
News Update

Neurosciences Firm Outlines Strategic Priorities for 2021

News Update
  ()
ProMIS Neurosciences discusses its four priority areas in 2021. read more >

Inari Shares Flow 14% Higher on Triple Digit YoY Growth in Procedures and Revenues

  ()
Shares of Inari Medical Inc. established a new 52-week high after the company reported that preliminary revenue in Q4/20 increased year-over-year by greater than 140%. read more >

As Psychedelics Move Mainstream, Small Cap Positions Itself at the Center of the Industry

  ()
Two year old DELIC Corp. has gotten in on the ground floor of the nascent psychedelic sector. read more >

A Novel, First-in-Class Blood Clotting Agent Takes Shape as a Bloody Compelling Investment

Contributed Opinion
  ()
Private start-up RxMP's safe way to stop bleeding inexpensively is already the envy of bigger players, states Dr. KSS, MD, PhD, editor-in-chief of PubBio.co. Can it go the distance through proof of concept? read more >

Mesoblast Reports Phase 3 Trial Data Showing Substantial Reductions in Cardiac and Stroke Events in CHF Patients

  ()
Shares of Mesoblast Ltd. traded 36% higher after the company reported positive results from its Phase 3 DREAM-HF study showing that a single dose of rexlemestrocel-L provided very significant decreases in heart attacks, strokes and cardiac death in patients diagnosed with chronic heart failure. read more >
News Update

Pharma Developer Outlines 2021 Clinical Program Initiatives

News Update
  ()
Algernon Pharmaceuticals provided an update detailing its plans for 2021 clinical trials. read more >

Chimerix Expands Late-Stage Oncology Pipeline Through $78M Oncoceutics Acquisition

  ()
Chimerix Inc. shares traded 65% higher after the company reported it entered into an agreement to acquire Oncoceutics Inc. in a combination stock and cash deal valued at $78 million plus milestone incentives totaling up to $360 million. read more >

Small-Cap Tech Stock Sees Huge Rise; What's Next?

Contributed Opinion
  ()
Technical analyst Clive Maund charts Leonovus and discusses what could lie ahead for the stock after it gained 150%. read more >

Change Healthcare Shares Surge 30% on $7.8B Merger with UNH's OptumInsight

  ()
Change Healthcare shares rose to a new 52-week high after the company reported it will be combining its operations with UnitedHealth's OptumInsight in an all cash purchase transaction for $25.75 per share. read more >

This Tiny Digital Healthcare Company's Sales Should Rocket Higher

Contributed Opinion
  ()
Independent financial analyst Matt Badiali profiles a small cap whose blood glucose monitoring system works with any smartphone. read more >

Biopharma's Acute Migraine Trial Yields Positive Efficacy, Safety Results

Research Report
  ()
The recently announced topline results from Axsome Therapeutics' MOVEMENT study are reviewed in a Ladenburg Thalmann report. read more >

This Tiny Tech Stock Is Quietly Building a Huge Business in Air Quality

Contributed Opinion
  ()
Independent financial analyst Matt Badiali discusses how mCloud's technology is making it possible for office buildings to reopen during the pandemic. read more >

Expert Investing Ideas

"AGN [shares] are now in a vigorous uptrend."

–Clive Maund, CliveMaund.com


"SPR is the number one cannabis stock to own today."

–Cynthia Berryman, Financial News Now



Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe
NASDAQ Biotech ARCA Pharmaceutical

Pandion Shares Get a Lift from Positive Top-Line Data in Phase 1a Autoimmune Disease Trial

  ()
Pandion Therapeutics shares traded 35% higher after the company reported positive top-line data from its Phase 1a clinical study of PT101 for treating autoimmune diseases including ulcerative colitis and systemic lupus erythematosus. read more >
News Update

Biopharma Appoints Adviser for Phase 3 COVID-19 Trial

News Update
  ()
Revive Therapeutics selects Dr. John Fahy, California-based pulmonary medicine expert and researcher, to join its team. read more >
News Update

Biopharma Recaps 2020 Accomplishments in COVID-19, Idiopathic Pulmonary Disease

News Update
  ()
Algernon Pharmaceuticals reports that it is aggressively advancing its repurposed drug, Ifenprodil. read more >